Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Coca-Cola HBC AG (CDI) (CCH) by Stephen Wright in The Motley Fool
- Watch Nexus Infrastructure (NEXS) by Steve Moore in ShareProphets
- Avoid WPP (WPP) by Steve Moore in ShareProphets
- Buy Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Tom Winnifrith in ShareProphets
- Buy Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Steve Moore in ShareProphets
- Hold Sylvania Platinum Ltd (DI) (SLP) by Tom Winnifrith in ShareProphets
- Hold Sylvania Platinum Ltd (DI) (SLP) by Steve Moore in ShareProphets
- Sell Ocado Group (OCDO) by Steve Moore in ShareProphets
- Neutral Aston Martin Lagonda Global Holdings (AML) by Citi
- Buy Glencore (GLEN) by Citi
- Buy London Stock Exchange Group (LSEG) by UBS
- Market Perform WPP (WPP) by Bernstein
- Buy Jet2 (JET2) by UBS
- Sell WPP (WPP) by UBS
- Equal Weight WPP (WPP) by Barclays
- Sell HSBC Holdings (HSBA) by Shore Capital
- Buy Luceco (LUCE) by Deutsche Bank
- Sell Haleon (HLN) by Deutsche Bank
- Buy Man Group (EMG) by Deutsche Bank
- Underweight Ocado Group (OCDO) by Barclays
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 19 open tips for Physiomics (PYC)
| Latest Bid : 0.45p | Latest Ask : 0.50p |
| High Today : 0.50p | Low Today : 0.45p |
| This Years High : 0.65p | This Years Low : 0.26p |
| Volume : 4,071,470 | MKT Cap : £0.97M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2026-02-16 16:20:00 16/02/2026 | 5.00% |
| Avoid | Steve Moore | Premium Only | 2025-02-13 13:45:00 13/02/2025 | 5.00% |
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | 20.83% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | 20.83% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 60.42% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.45p | Latest Ask : 0.50p |
| High Today : 0.50p | Low Today : 0.45p |
| This Years High : 0.65p | This Years Low : 0.26p |
| Volume : 4,071,470 | MKT Cap : £0.97M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2026-02-16 16:20:00 16/02/2026 | 5.00% |
| Avoid | Steve Moore | Premium Only | 2025-02-13 13:45:00 13/02/2025 | 5.00% |
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | 20.83% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | 20.83% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 60.42% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000